Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Epilepsy surgery outcome in temporal lobe cavernoma and multiple sclerosis.
No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus.
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
The expanded spectrum of neuromyelitis optica: evidences for a new definition.
The relatively benign course of patients initially presenting with unilateral optic neuritis.
Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.
Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis.
Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Anti-IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in CR-EAE ABH Mice.
Chronic constipation and co-morbidities: A prospective population-based nested case-control study.
Exploring meanings of illness causation among those severely affected by multiple sclerosis: a comparative qualitative study of Black Caribbean and White British people.
Inflammasomes and human autoimmunity: A comprehensive review.
Oligodendrogenesis in the normal and pathological central nervous system.
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.
Intranetwork and internetwork functional connectivity abnormalities in pediatric multiple sclerosis.
Myelin proteomics: the past, the unexpected and the future.
Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: A 7 Tesla MRI study.
Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis.
Validity and test-retest reliability of a measure of hand sensibility and manual dexterity in people with multiple sclerosis: the ReSense test.
Molecular interplay between T-Antigen and splicing factor, arginine/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells.
Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions.
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
Pages
« first
‹ previous
…
452
453
454
455
456
457
458
459
460
…
next ›
last »